Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Pliant Therapeutics Inc
F:9PT
Pliant Therapeutics Inc
F:9PT
Price:
0.922
EUR
-3.4%
Market Closed
Market Cap:
€55.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
P
|
Pliant Therapeutics Inc
F:9PT
|
US |
|
A
|
Ameriprise Financial Inc
BMV:AMP
|
US |
|
C
|
Compagnie des Alpes SA
SWB:JCA
|
FR |
|
GLG Corp Ltd
ASX:GLE
|
SG |
|
S
|
Savannah Energy PLC
LSE:SAVE
|
UK |
|
B
|
Balfour Beatty PLC
F:BIH
|
UK |
|
Morguard Corp
TSX:MRC
|
CA |
|
Morguard Corp
F:74S
|
CA |
|
M
|
Mid-America Apartment Communities Inc
F:M2K
|
US |
Wall St Price Targets
9PT Price Forecast
Based on 3 analysts
Based on 3 analysts
+178% Upside
from
€0.922
today
Pliant Therapeutics Inc (9PT)’s 12-month stock price forecast through September 2027 has a consensus target of €2.563, implying 178% upside. The forecast is based on price targets from 3 Wall Street analysts.
9PT Analyst Rating
No ratings yet
No ratings yet
Pliant Therapeutics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 9PT's stock price target?
Price Target
2.563
EUR
2.563
EUR
According to Wall Street analysts, the average 1-year price target for 9PT is 2.563 EUR with a low forecast of 2.538 EUR and a high forecast of 2.638 EUR.